Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Grahame Morris

Grahame Morris

United Kingdom · Official source

Memberships

  • Labour · Commons · present
  • · Commons · 6 May 2010 – present

Votes

Browse all 261 votes

Showing the 24 most recent votes of 261. Browse the full list

Records

Browse all 37 records
Motion· Early Day MotionEDM 1018open

Needle and syringe programmes

United Kingdom · UK Parliament · 21 October 2026

That this House welcomes the Out of Reach report, published by the Hepatitis C Trust, alerting us to the declining access to needle and syringe programmes (NSPs) and the threat to public health; notes that NSPs are an evidence-based public health intervention which help prevent the transmission of hepatitis C, hepatitis B and HIV and provide an important point of contact with wider health and support services; notes with concern that only 26% of responding local authorities showed a strong understanding of NSP provision in their area; further notes that, of pharmacies identified through local sources as providing NSP services, only 47% were confirmed as doing so; is further concerned that one third of pharmacies contacted in both the 2023 and 2025 mapping exercises reported that they had stopped providing NSP services; further notes significant variation in the accessibility and quality of NSP provision, including restrictions on the amount of injecting equipment available; recognises the vital role of community pharmacies, drug and alcohol services, outreach services and peer-led organisations in providing high-quality, accessible harm reduction services; believes that accurate and comprehensive information on NSP availability and quality is essential to effective public health planning and the prevention of blood-borne viruses; and calls on the Government to undertake a national evaluation of NSP provision and take action to ensure that NSP provision is adequately monitored, commissioned and resourced across England.

Motion· Early Day MotionEDM 966open

Support for outsourced gatesolutions catering workers at LNER

United Kingdom · UK Parliament · 15 October 2026

That this House commends the work of outsourced catering workers who supply LNER trains with food along the route between London and Edinburgh; notes that providing a high quality catering offer will be vital to ensuring that Great British Railways is able to provide an attractive offer to passengers; further notes with concern that catering staff who supply LNER trains are currently outsourced to gatesolutions, an arm of Swiss multinational Gate Group, whose turnover last year was £4.7 billion; is disturbed to learn that the management of gatesolutions are now refusing to honour the Real Living Wage, having previously paid it; is dismayed that some of these workers, who are disproportionately from BME backgrounds and work unsocial hours, will now face rates barely above the statutory minimum; believes that this undermines the Government’s aspiration that Great British Railways be one railway, one team, a champion of diversity and an employer of choice; calls on publicly owned LNER to bring its contractor into line and ensure that a pay offer is made that resolves the dispute; and further calls on the Government to direct LNER to begin discussions with the RMT over insourcing this contract.

Motion· Early Day MotionEDM 949open

Planned job losses at Greggs plc

United Kingdom · UK Parliament · 13 October 2026

That this House deeply regrets the announcement by high street bakery retailer Greggs that it plans to close four manufacturing sites across the UK with the loss of 740 jobs; notes that the plans involve closing manufacturing sites at Seaham, North Lakes, Kelso, and Enfield, with operations in Treforest and Manchester also seriously impacted; further notes that in the first half of 2026, the company saw its pre-tax profit increase by 19.7% to £76.0 million; joins with the Bakers, Food and Allied Workers Union in believing that this success would be impossible without the contribution of workers across the business, and regrets the impact which job losses would have on the individuals, families and local communities concerned; regrets that the company announced these plans further to any formal consultation process with the recognised unions; and therefore calls on the company to pause the implementation of the closures and get round the table with the unions to consider alternatives to site closures and compulsory redundancies.

Motion· Early Day MotionEDM 905open

Tackling stigma

United Kingdom · UK Parliament · 12 October 2026

That this House commends Drugs: It’s Complicated, the series of short films produced by Dr Adam Holland at the University of Bristol and funded by the Medical Research Council; welcomes this exemplary intervention as an effective contribution to understanding drug use and users, challenging prevalent negative stereotypes; recognises that this series takes a balanced view, lending clarity to what are indeed complex issues; thanks all those assisting in the production and dissemination of these films; acknowledges that everyone has a part to play in tackling stigma; and calls upon the Government to adopt a positive approach by supporting this and similar initiatives, the efforts of the Anti-Stigma Network and all those challenging stigma, thereby helping to remove barriers to treatment and reduce the record level of drug deaths across the UK.

Motion· Early Day MotionEDM 747open

Radiotherapy road map to improved cancer treatment plan

United Kingdom · UK Parliament · 3 September 2026

That this House welcomes the National Cancer Plan's commitment to restore the three cancer waiting time standards by March 2029 and end the postcode lottery in cancer treatment; notes with regret that the Plan sets no radiotherapy trajectory, milestone or accountable body to deliver that ambition; further notes that NHS data shows performance against the 62-day referral-to-treatment standard is lowest for radiotherapy of the three main modalities, and that improving it requires clinical expertise from across the country; also notes that commissioning now rests with Integrated Care Boards, that Freedom of Information requests in 2023 found around 70 per cent had no named radiotherapy lead, and that most contain only one or two centres, leaving a highly specialised, capital-intensive service without the scale, data or expertise it requires; observes that this fragmentation delays innovation, as shown by artificial intelligence auto-contouring funding not taken forward and by prostate stereotactic ablative radiotherapy, commissioned only in 2026 despite 2023 evidence, and that adaptive, molecular and other advanced radiotherapy risk the same fate; recalls that the original National Radiotherapy Advisory Group oversaw the national rollout of intensity-modulated radiotherapy and contributed to an estimated 2,500 lives saved a year, equivalent to 3,000 today; and calls on the Government to establish an independent, clinician-led National Radiotherapy Advisory Group and implementation group, including patient representation, empowered to set a national framework against which each Board publishes a radiotherapy action plan, and to place accountability for radiotherapy standards on a statutory footing through the NHS Modernisation Bill.

Showing the 24 most recent records of 37. Browse the full list